# EDGAR Filing Document

**Accession Number:** 0001734722
**File Stem:** 0001562180-25-005182
**Filing Date:** 2025-7
**Character Count:** 10160
**Document Hash:** fd90119d78923a24869196944f687f3f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001562180-25-005182.hdr.sgml**: 20250701

**ACCESSION NUMBER**: 0001562180-25-005182

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250626

**FILED AS OF DATE**: 20250701

**DATE AS OF CHANGE**: 20250701

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Somasegar Sivaramakichenane
- **CENTRAL INDEX KEY:** 0002031410

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40348
- **FILM NUMBER:** 251096569

**MAIL ADDRESS:**
- **STREET 1:** 999 THIRD AVENUE
- **STREET 2:** SUITE 3400
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98104
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UiPath, Inc.
- **CENTRAL INDEX KEY:** 0001734722
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 474333187
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**BUSINESS ADDRESS:**
- **STREET 1:** ONE VANDERBILT AVENUE
- **STREET 2:** 60TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** (844) 432-0455

**MAIL ADDRESS:**
- **STREET 1:** ONE VANDERBILT AVENUE
- **STREET 2:** 60TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

## Ex-24

```

AUTHORIZATION LETTER

May 20, 2025

Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attn: Filing Desk

To Whom It May Concern:

By means of this letter I authorize Brad Brubaker,
Andy Benton, Laura Rodgers, and Stephanie Marcozzi
or any of them individually, to sign on my behalf
all forms required under Section 16(a) of the Securities
Exchange Act of 1934, as amended, relating to transactions
involving the stock or derivative securities of
UiPath, Inc. Any of these individuals is accordingly
authorized to sign any Form ID, Form 3, Form 4,
Form 5 or amendment to those forms that I am required
to file with the same effect as
if I had signed them myself.

This authorization will remain in effect until revoked in
writing by me.

Yours truly,

/s/ Sivaramakichenane Somasegar

POWER OF ATTORNEY

Know all by these presents, that the undersigned
hereby constitutes and appoints each of Brad
Brubaker, Andy Benton, Laura Rodgers, and
Stephanie Marcozzi, signing individually the
undersigneds true and lawful
attorneys-in-fact and agents to:

(1) execute for and on behalf of the undersigned,
in the undersigneds capacity as an executive officer,
member of the Board of Directors and or greater
than 10% stockholder of UiPath, Inc. (the Company),
Forms 3, 4 and 5 (including any amendments thereto)
in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended (the Exchange Act),
and the rules thereunder;

(2) do and perform any and all acts for and on behalf
of the undersigned which may be necessary or desirable
to complete and execute any such Forms 3, 4 or 5
(including any amendments thereto) and timely file such
forms with the Securities and Exchange Commission and
any stock exchange or similar authority; and

(3) take any other action of any nature whatsoever in
connection with the foregoing which, in the opinion of
such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned,
it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-facts discretion.

The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or
could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-facts
substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights
and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the
undersigneds responsibilities to comply with Section 16
of the Exchange Act.

This Power of Attorney shall remain in full force and
effect until the earliest to occur of (a) the undersigned
is no longer required to file Forms 3, 4 and 5 with respect
to the undersigneds holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact,
or (c) as to any attorney-in-fact individually, until
such attorney-in-fact is no longer employed by the Company,
as applicable.

The undersigned has caused this Power of Attorney to be
executed as of May 20, 2025.

/s/ Sivaramakichenane Somasegar

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Somasegar Sivaramakichenane<br><sub>(Last) (First) (Middle)</sub><br>C/O UIPATH, INC.<br>ONE VANDERBILT AVENUE, 60TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10017<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-26 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>UiPath, Inc. [ PATH ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2025-06-26 |  | A<sup>(1)</sup> |  | 16064.00<sup>(2)</sup> | A | $0.00 | 63758.00 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) This grant was made pursuant to the issuer's non-employee director compensation policy.

(2) Includes 16,064 Restricted Stock Units (RSUs).  Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement.  Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting (or the date immediately prior to the next annual meeting, if the non-employee director's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), or the first anniversary of the date of grant, in each case subject to the director's continued service through such vesting date.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** Brad Brubaker, as Attorney-in-Fact  
**Date:** 2025-06-30

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**